Steve Marshall “disappointed” with Supreme Court decision to stay ruling in abortion pill case

Alabama Attorney General Steve Marshall (R) on Friday expressed his disappointment with a United States Supreme Court decision granting stay in the abortion pill case.

“While I am disappointed that the stay has remained in place, I am confident the appeals process will reinforce that President [Joe] Biden lacked the authority to enact a dangerous mail-order abortion regime,” said AG Marshall. “As the last line of defense against President Biden’s radical agenda, I will continue to do everything in my power to protect mothers and the life of the unborn.”

The U.S. Supreme Court’s decision comes after the Biden Administration appealed a U.S. Federal District Court decision in Texas halting the Federal Drug Administration’s (FDA) approval of chemical abortions as well as its removal of important safety measures associated with the administration of abortion pills. Marshall has joined an amicus brief urging the Supreme Court to leave the lower court order in place, which blocked the FDA’s mail-order abortion regime.

The Supreme Court on Friday granted emergency requests from the Biden administration and New York-based Danco Laboratories to stay the Texas decision. They are appealing a lower court ruling that would roll back the Food and Drug Administration’s approval of mifepristone – a drug used in over half of the abortions in this country.

The drug has been approved for use in the U.S. since 2000, despite numerous reports of side effects, including death.

The Texas Court accepted the position of pro-life activists and recognized their argument that the abortion pill is dangerous, and rolled back Biden’s mail-order abortion scheme.

Susan B. Anthony List Pro-Life America said in a statement, “The FDA has one job: safeguarding the lives and health of Americans. The evidence clearly shows their failure when it comes to the abortion pill. First, the FDA inappropriately fast-tracked this dangerous drug for approval without studying its effects in teenage girls. Then under the Obama and Biden administrations, they loosened one safety standard after another – finally approving mail-order abortion drugs and ignoring the critical importance of in-person doctor supervision – and stonewalled those who sought accountability. The rate of abortion pill-related emergency room visits has skyrocketed over 500% since it was approved, while the drug manufacturers have made a handsome profit – with investors reaping a 452% return on average. The FDA ignored science and placed politics over the safety of women and girls, as well as the lives of countless unborn children. Finally, they are beginning to be held accountable.”

The Biden Administration maintains that abortion is essential healthcare and that the potential side effects of mifepristone are outweighed by the potential health side effects of an unwanted pregnancy.

The Supreme Court’s action Friday will leave access to mifepristone unchanged at least into next year, as the case moves through the appeals process, including a potential appeal to the Supreme Court. The case will first be at the New Orleans-based U.S. Court of Appeals for the 5th Circuit, which has set arguments in the case for May 17.

To connect with the author of this story or to comment, email brandonmreporter@gmail.com.